Our Advisors are leaders and experts in the fields of 

regenerative medicine, operations, technology and quality.

Our management team brings decades of cellular therapy, tissue, blood banking, and technology expertise combined with

quality systems, innovation, and LEAN Six Sigma excellence.

LINDA S. BARNES, MHA, RAC

FOUNDER AND CEO

Ms. Linda Barnes is the CEO and President of X-CellSystem International.  She has an extensive background in cell therapies, blood services, and public health research with more than 25 years’ experience in complex healthcare delivery operations; quality assurance and regulatory affairs pertaining to blood and transfusion services and tissues; research program management; and health systems strengthening.  She is an implementation expert in the field of cellular therapies, ranging from advancing first-in-class immunotherapies to delivering blood services in low-resource settings.  Over the course of her career, she has provided technical consultation on quality management in blood transfusion services for the People’s Republic of China, Uganda, Ukraine, Kazakhstan, Guyana, the Caribbean Region, and Turks and Caicos Islands in the British West Indies.  She is active within AABB as a domestic and international assessor for BB/TS and CT and serves as co-chair of the Policy and Practice Improvement sub-committee for the Global Transfusion Medicine Forum of the AABB.  She is also a member of the Standards Coordinating Body for Regenerative Medicines.  She is a board member for Performance Excellence Northwest, the Malcolm Baldrige Regional Quality organization, and is a credentialed Baldrige Examiner. 

Ms. Barnes obtained her master’s degree in health services from the University of Washington, is board-certified in Regulatory Affairs (Regulatory Affairs Professionals Society) and is currently a public health doctoral candidate at University of Illinois-Chicago. 

Our Advisors

Tammy Buist.jpg

TAMMY BUIST

MBA

VP and Chief Business Development at

Cancer Research and Biostatistics (CRAB)

Self-starter professional with over 20 years business and executive experience in the biotechnology / pharmaceutical industry including Merger and Acquisitions and start-ups. Founder / Executive of three successful public biotechnology companies.

Ken Grabstein_edited_edited_edited.jpg

KENNETH GRABSTEIN

PhD

Immunologist, Co-Founder of Corixa Corp. and served as Executive VP of Product Development

Director of Cellular Immunology and Flow Cytometry Facility at Immunex Corp.

Co-founder and Chief Scientific Officer of Allozyne, Inc.  Affiliate Professor of Chemical Engineering at University of Washington.

Heidi Hagen.jpg

HEIDI HAGEN

MSBE, MBA

Chief Strategy Officer, Co-founder at Vineti

A seasoned Biotechnology and Operations executive. Successfully built organizations and programs within both established and start up environments, commercialized innovative operations, designed and built commercial manufacturing facilities, and streamlined complicated logistics and production systems.

JKrauser.jpeg

JARY KRAUSER

President and CEO at Stratus G

Experienced throughout all phases of the product development pipeline, from concept through research, development and commercialization. Implemented hundreds of regulated systems including a Laboratory Information Management System for stability, environmental monitoring, and materials management. 

Iyabo Tinubu-Karch, MD

S. IYABO TINUBU-KARCH

MD, MHA

CEO at 6M Geriatrics & Hospital Medicine, PLLC

Experienced Consultant Physician and Physician Executive; especially in turn around settings. Excellent change manager in the rapid deployment phase of start up projects. Focused Interest in building human resource capital, and population health delivery in resource/ revenue challenged environments.

G. Wisegarver_edited.jpg

GLENN WISEGARVER

CPA, MBA, CGMA

Founder and CEO at SigmaIQ

A Senior Finance Executive with a reputation for strong leadership, strategic management, financial acumen, and tactical execution who builds talented worldwide teams. An engaged partner with peers, providing financial clarity and innovative solutions to support organizational growth and transformation. 

Management, Sciences, and Investments through

ELEV8BIO MANAGEMENT TEAM

 

Cecilia Zapata-Harms, MS, MHA, CPC - CEO & Managing Partner

David Lawrence - CVO & Managing Partner

Stephen Martin - Legal & Regulatory/Compliance

Prashanth Chintanapalli - Investor Relations

ELEV8BIO SCIENTIFIC ADVISORS

Vijayakrishna K. (VK) Gadi, MD, PhD

Andrei R. Shustov, MD

Legal Counsel for Great Businesses through

Member of